Clinical Research Facility

Rogers, Arkansas 72758

We've found

6 trials

at this facility

Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Rogers, AR

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Status: Enrolling, Phase IV
Updated: 11/2/2015

from

Rogers, AR

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Rogers, AR

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Rogers, AR

Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis

Status: Enrolling, Phase III
Updated: 2/7/2017

from

Rogers, AR

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Rogers, AR

Use our guide to learn which trials are right for you!